Glia, LLC
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Dis Ocular Graft-versus-host Disease | Phase 2 / Phase 3 | 2021-04-15 |
| Completed | Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT. Chronic Ocular Graft-versus-host Disease | Phase 2 | 2019-10-17 |
| Completed | Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel Contact Lens Discomfort, Contact Lens-induced Corneal Disorder, Contact Lens Acute Red Eye | Phase 2 | 2019-06-27 |
| Completed | Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 Ocular Surface Disease | Phase 2 | 2016-01-22 |